Current status:
Cancelled Post Market
Current status date:
2000-06-14
Product name:
LERITINE INJ 25MG/ML
DIN:
00009857
Electronic product monograph is not available
Route(s) of administration:
Intramuscular
,
Intravenous
,
Subcutaneous
Number of active ingredient(s):
1
Schedule(s):
Narcotic (CDSA I)
Anatomical Therapeutic Chemical (ATC):
See footnote 4
N01AH05 ANILERIDINE
List of active ingredient(s)
Active ingredient(s)
See footnote8
|
Strength |
ANILERIDINE (ANILERIDINE PHOSPHATE)
|
25 MG / ML
|